Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Silvestre

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Diabetes & Metabolism|April 12, 2008
Vascular progenitor cells and diabetes: role in postischemic neovascularisationJ-S Silvestre
Methods and Findings in Experimental and Clinical Pharmacology|January 4, 2007
Pleiotropic effects of statins and related pharmacological experimental approachesM Alegret, J S Silvestre
Cardiovascular Research|October 28, 1999
Aldosterone and the heart: towards a physiological function?C Delcayre, J S Silvestre
Timely Topics in Medicine. Cardiovascular Diseases|May 3, 2007
Pleiotropic effects of statins and related pharmacological experimental approachesM Alegret, J S Silvestre
Methods and Findings in Experimental and Clinical Pharmacology|August 6, 2005
Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetesJ S Silvestre, J Prous
Methods and Findings in Experimental and Clinical Pharmacology|September 7, 2004
Insulin analogues in the management of diabetesM Vázquez-Carrera, J S Silvestre
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 10, 2002
Angiogenesis therapy in ischemic diseaseJ S Silvestre, B I Lévy
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 24, 2001
[Hypertension: microvascular complications]J S Silvestre, B I Lévy
Annales De Cardiologie Et D'Angeiologie|May 20, 2006
[Diabetes and peripheral arterial occlusive disease: therapeutic potential and pro-angiogenic strategies]J S Silvestre, B I Lévy
Methods and Findings in Experimental and Clinical Pharmacology|November 6, 2007
Comparative evaluation of hERG potassium channel blockade by antipsychoticsJ S Silvestre, J R Prous
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Diabetes & Metabolism|April 12, 2008
Vascular progenitor cells and diabetes: role in postischemic neovascularisationJ-S Silvestre
Methods and Findings in Experimental and Clinical Pharmacology|January 4, 2007
Pleiotropic effects of statins and related pharmacological experimental approachesM Alegret, J S Silvestre
Cardiovascular Research|October 28, 1999
Aldosterone and the heart: towards a physiological function?C Delcayre, J S Silvestre
Timely Topics in Medicine. Cardiovascular Diseases|May 3, 2007
Pleiotropic effects of statins and related pharmacological experimental approachesM Alegret, J S Silvestre
Methods and Findings in Experimental and Clinical Pharmacology|August 6, 2005
Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetesJ S Silvestre, J Prous
Methods and Findings in Experimental and Clinical Pharmacology|September 7, 2004
Insulin analogues in the management of diabetesM Vázquez-Carrera, J S Silvestre
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 10, 2002
Angiogenesis therapy in ischemic diseaseJ S Silvestre, B I Lévy
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 24, 2001
[Hypertension: microvascular complications]J S Silvestre, B I Lévy
Annales De Cardiologie Et D'Angeiologie|May 20, 2006
[Diabetes and peripheral arterial occlusive disease: therapeutic potential and pro-angiogenic strategies]J S Silvestre, B I Lévy
Methods and Findings in Experimental and Clinical Pharmacology|November 6, 2007
Comparative evaluation of hERG potassium channel blockade by antipsychoticsJ S Silvestre, J R Prous
Pageof 5